Relugolix and Enzalutamide Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Oklahoma City, Oklahoma1 trial

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Stephenson Cancer Center at OU Health, University of Oklahoma Health Sciences Center (SCC-OUHSC)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.